A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: D. Romaniello, L. Mazzeo, M. Mancini, I. Marrocco, A. Noronha, M. Kreitman, S. Srivastava, S. Ghosh, M. Lindzen, T.M. Salame, A. Onn, J. Barr, Y. Yarden

Journal title: Clinical Cancer Research

Journal number: November 15, 2018

Journal publisher: AACR

Published year: 2018

Published pages: 5610-5621

DOI identifier: 10.1158/1078-0432.ccr-18-0450

ISSN: 1557-3265